Our data suggest the following scenario: upon EBV infection, the viral gene product LMP1 activates, via its cytoplasmic C-terminal activator regions CTAR1 and CTAR2, the NF-κB pathway leading to vtRNA1-1 upregulation. The gene discussed is NFKB1; the disease is Epstein-Barr virus infection.